UW Health — research payments reported

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$148,889	2
2024	Research	$35,283	1
2021	Research	$16,792	6
2020	Research	$3,520	4
2019	Research	$9,504	5

Breakdown

Who paid Research payments · program years 2019–2025

Celgene Corporation $184,127 2 payments
Genentech, Inc. $11,288 3 payments
Mallinckrodt Enterprises LLC $9,504 5 payments
F. Hoffmann-La Roche AG $5,504 3 payments
Mallinckrodt Hospital Products Inc. $3,520 4 payments
Incyte Corporation $45 1 payment

Studies the money was for Research payments · program years 2019–2025

A Phase 1, Multi-center, Open-label, Dose Finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Cc-94676 in Subjects With Metastatic Castration-resistant Prostate Cancer $148,844 1 payment
Ph I FIH mCRPC mono CC-94676-PCA-001 - A phase 1, multi-center, open-label, dose finding study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cc-94676 in subjects with metastatic castration-resistant prostate cancer $35,283 1 payment
Patient Experience and Preference $16,792 6 payments
Stratagraft Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements $12,672 8 payments
Stratagraft Skin Tissue As An Alternative to Autografting Full-Thickness Complex Skin Defects $352 1 payment
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo $45 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.